Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [ef109896-069c-451f-89b9-0da36c918104] => Array ( [runtime-id] => ef109896-069c-451f-89b9-0da36c918104 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [54e48194-42f7-4e96-ad7e-54a56afad6f7] => Array ( [runtime-id] => 54e48194-42f7-4e96-ad7e-54a56afad6f7 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;d47f3f5554fa9c887ddc86ed607b86ab276d5dad ) ) ) 1naresh2naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [ef109896-069c-451f-89b9-0da36c918104] => Array
        (
            [runtime-id] => ef109896-069c-451f-89b9-0da36c918104
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [54e48194-42f7-4e96-ad7e-54a56afad6f7] => Array
                        (
                            [runtime-id] => 54e48194-42f7-4e96-ad7e-54a56afad6f7
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;d47f3f5554fa9c887ddc86ed607b86ab276d5dad
                )

        )

)

Table 1: Histologic diagnosis and patient demographics
Patient Sex Age (yr) Pathology Status
1 Male 51 Glioblastoma, astrocytic, gemistocytic Postbiopsy, postradiation (6 mo)^{^a}
2 Male 53 Glioblastoma, astrocytic, small cell Postbiopsy, postradiation (8 mo)^{^a}
3 Male 84 Glioblastoma, astrocytic, small cell Prebiopsy, preradiation
4 Male 66 Glioblastoma, astrocytic, gemistocytic Prebiopsy, preradiation
5 Male 55 Primary CNS lymphoma, large B-cell Postbiopsy, preradiation
6 Female 74 Primary CNS lymphoma, large B-cell Prebiopsy, preradiation
7 Male 67 Primary CNS lymphoma, large B-cell Prebiopsy, preradiation
8 Female 72 Metastatic adenocarcinoma, primary colon Prebiopsy, postradiosurgery (14 mo)^{^a}
9 Male 58 Metastatic renal cell carcinoma Prebiopsy, postradiosurgery (10 mo)^{^a}
10 Female 73 Metastatic non-small cell lung Prebiopsy, postradiosurgery (6 mo)^{^a}
↵a Interval in months between radiation treatment and MRI.

Patient	Sex	Age (yr)	Pathology	Status
1	Male	51	Glioblastoma, astrocytic, gemistocytic	Postbiopsy, postradiation (6 mo)^{^a}
2	Male	53	Glioblastoma, astrocytic, small cell	Postbiopsy, postradiation (8 mo)^{^a}
3	Male	84	Glioblastoma, astrocytic, small cell	Prebiopsy, preradiation
4	Male	66	Glioblastoma, astrocytic, gemistocytic	Prebiopsy, preradiation
5	Male	55	Primary CNS lymphoma, large B-cell	Postbiopsy, preradiation
6	Female	74	Primary CNS lymphoma, large B-cell	Prebiopsy, preradiation
7	Male	67	Primary CNS lymphoma, large B-cell	Prebiopsy, preradiation
8	Female	72	Metastatic adenocarcinoma, primary colon	Prebiopsy, postradiosurgery (14 mo)^{^a}
9	Male	58	Metastatic renal cell carcinoma	Prebiopsy, postradiosurgery (10 mo)^{^a}
10	Female	73	Metastatic non-small cell lung	Prebiopsy, postradiosurgery (6 mo)^{^a}